A subtype of cancer‐associated fibroblast expressing syndecan‐2 (SDC2) predicts survival and immune checkpoint inhibitor response in gastric cancer. - Sung, Ji‐Yong; Cheong, Jae‐Ho; Shin, Kihye; Kim, Eui Tae (Clinical & Translational Medicine, 2024)